
Burning Rock Biotech Ltd
NASDAQ:BNR

Intrinsic Value
The intrinsic value of one
BNR
stock under the Base Case scenario is
15.16
USD.
Compared to the current market price of 3.23 USD,
Burning Rock Biotech Ltd
is
Undervalued by 79%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Burning Rock Biotech Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Burning Rock Biotech Ltd
Balance Sheet Decomposition
Burning Rock Biotech Ltd
Current Assets | 776.6m |
Cash & Short-Term Investments | 519.8m |
Receivables | 165.9m |
Other Current Assets | 90.9m |
Non-Current Assets | 108.7m |
PP&E | 100.3m |
Intangibles | 421k |
Other Non-Current Assets | 7.9m |
Free Cash Flow Analysis
Burning Rock Biotech Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Burning Rock Biotech Ltd
Revenue
|
515.8m
CNY
|
Cost of Revenue
|
-153.4m
CNY
|
Gross Profit
|
362.4m
CNY
|
Operating Expenses
|
-684.8m
CNY
|
Operating Income
|
-322.4m
CNY
|
Other Expenses
|
-24.2m
CNY
|
Net Income
|
-346.6m
CNY
|
BNR Profitability Score
Profitability Due Diligence
Burning Rock Biotech Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Score
Burning Rock Biotech Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
BNR Solvency Score
Solvency Due Diligence
Burning Rock Biotech Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
Burning Rock Biotech Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BNR Price Targets Summary
Burning Rock Biotech Ltd
Dividends
Current shareholder yield for BNR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
BNR
stock under the Base Case scenario is
15.16
USD.
Compared to the current market price of 3.23 USD,
Burning Rock Biotech Ltd
is
Undervalued by 79%.